Not Yet Recruiting
Chemotherapy Sequential Tislelizumab After Radical Resection in Patients With dMMR/MSI-H or POLE/POLD1 Mutations
NCT06118658
- Conditions
- Colorectal Adenocarcinoma, Gastric
- Locations
-
- Liaoning Cancer Hospital & Institute Shenyang, Liaoning, China